HOME >> MEDICINE >> NEWS
Use of inhaled corticosteroid led to fewer hospitalizations for young children with asthma

San Antonio, Tex. March 19, 2005 A new study, presented at the 61st annual American Academy of Allergy, Asthma and Immunology (AAAAI) showed that children who were prescribed a nebulized inhaled corticosteroid (ICS) as first-line treatment for asthma, experienced fewer emergency department (ED) visits or hospitalizations than children prescribed the medication as second or third-line treatment . Asthma is the most common chronic medical condition among children under the age of 15 and the third leading cause of hospitalization in this age group.4

In the study, 25 percent of children who received nebulized ICS as an initial therapy had to visit an ED or stay in the hospital at least once during one year of follow-up, compared to nearly 30 percent who had nebulized ICS as a secondary treatment, and 40 percent who took it as a third line treatment.

"Pediatric patients who were prescribed nebulized ICS earlier in treatment had a lower rate of exacerbations," said Kevin Murphy, MD, Clinical Professor of Pediatrics at the University of Nebraska Medical Center, and principal investigator in the study.

The study assessed whether early controller medications, such as the nebulized ICS Pulmicort Respules (budesonide inhalation suspension), were associated with improved outcomes for children with asthma. The trial evaluated a total of 11,407 patients aged 12 months to four years who were diagnosed with asthma. Researchers evaluated exacerbation rates during a 12-month period following the first asthma medication prescription. In this study, exacerbation was defined as one or more ED visits or hospitalizations during the study period.

Parents who recognize the symptoms of asthma in their children coughing, wheezing, chest tightness, and shortness of breath should inform their doctor or healthcare provider and obtain a proper diagnosis of the condition. Treatment options for childhood asthma can be broken down into two catego
'"/>


21-Mar-2005


Page: 1 2 3 4

Related medicine news :

1. Specialty medical societies offer evidence-based conclusions on inhaled steroid treatment for asthma
2. Treatment helped reduce dose of inhaled corticosteroids while maintaining asthma control
3. New data examines effect of inhaled corticosteroids (ICS) on survival in patients with COPD
4. NHLBI researchers find long-acting beta-agonists not as effective as inhaled corticosteroids in treating persistent asthma
5. Intranasal corticosteroid receives FDA pregnancy Category B rating for allergic rhinitis
6. Generic anti-inflammatory causes significantly fewer GI complications than branded medications
7. Close control of blood pressure associated with fewer eye problems in patients with type 2 diabetes
8. Study links warm offices to fewer typing errors and higher productivity
9. University of Pittsburgh approach has lung recipients taking far fewer drugs
10. Study finds fewer, but more advanced, colon cancers in postmenopausal women on E&P hormone therapy
11. Novel prostate cancer marker may lead to earlier diagnosis and fewer repeat bioposies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/17/2019)... ... July 17, 2019 , ... Dynamic ... in Medicare Advantage, Medicaid, and Marketplace programs is pleased to announce the introduction ... Health Records (EHR) integration at the point of care to providers and ...
(Date:7/17/2019)... ... July 17, 2019 , ... This past Saturday, Monarch Dental® hosted ... . Over 50 underserved patients were welcomed at the Mesquite office to receive free ... summer season. Individuals were referred to the event through local nonprofit organizations such as ...
(Date:7/17/2019)... (PRWEB) , ... July 17, 2019 , ... Women’s Excellence is pleased to announce a ... summer in September. The new offices resides on the corner of Turrill Road and ... We are thrilled about the opening of our new office in Lapeer and the ...
(Date:7/13/2019)... ... July 12, 2019 , ... ... of its proprietary patient management platform, Ospitek “View”. Ospitek has partnered with some ... deliver a fully customizable, intelligent, solution made specifically for surgical centers, allowing them ...
(Date:7/12/2019)... SCOTCH PLAINS, N.J. (PRWEB) , ... July 12, 2019 , ... ... been reviewed and approved by NJ Top Docs for 2019. Located in Paramus, BAXT ... has been providing state-of-the-art cosmetic and medical dermatological care for the past 45 years. ...
Breaking Medicine News(10 mins):
(Date:7/11/2019)... ... July 11, 2019 , ... Voted one of ... and considered by a luminary of the cosmetic world to “represent a revolutionary ... Sciadonic Acid DELTA-5, derived from exotic conifer seeds. DELTA-5 technology works to reduce ...
(Date:7/11/2019)... JERSEY CITY, N.J. (PRWEB) , ... July 11, ... ... at Indiana MGMA , GRM Information Management, a leading provider of enterprise content ... Annual Conference in French Lick, Indiana July 17 to July 19. , ...
(Date:7/11/2019)... ... July 11, 2019 , ... Twenty-one ... among Castle Connolly’s Top Doctors. All of these professionals are recognized as Atlanta’s ... physicians in the publication’s urology category and all of the physicians in the ...
Breaking Medicine Technology:
Cached News: